2149 — BaTeLab Co Income Statement
0.000.00%
Last trade - 00:00
- HK$1.96bn
- HK$1.93bn
- CNY463.88m
- 12
- 32
- 53
- 19
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 88.7 | 213 | 353 | 464 |
Cost of Revenue | ||||
Gross Profit | 48.7 | 120 | 199 | 257 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 70.7 | 152 | 254 | 350 |
Operating Profit | 18 | 60.8 | 98.5 | 113 |
Total Net Non Operating Interest Income / Expense | ||||
Net Income Before Taxes | 14 | 57 | 96.8 | 109 |
Provision for Income Taxes | ||||
Net Income After Taxes | 14 | 57 | 95.3 | 109 |
Net Income Before Extraordinary Items | ||||
Net Income | 14 | 57 | 95.3 | 109 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 14 | 57 | 95.3 | 109 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.23 | 0.95 | 1.59 | 2.45 |